Navigation Links
Mattel Children's Hospital UCLA launches program in nanopediatrics
Date:10/17/2008

Mattel Children's Hospital UCLA today announced the launch of the Mattel UCLA NanoPediatrics Program, which will explore the future of personalized medicine for children, including the opportunities and risks involved. The program is one of the world's first dedicated solely to nanomedicine and pediatric patients.

"Why develop a nanopediatrics program? Because children are not small adults," said Dr. Edward McCabe, physician-in-chief of Mattel Children's Hospital and founding director of the new program. "We know that drugs affect children they metabolize, excrete and may even utilize, developmentally, specific receptors differently than adults.

"Unless children are included as a research priority for the application of nanotechnology, then we will simply be applying approaches developed for adults. This flawed strategy will place children at risk, as opposed to a program in which children will be the focus from the outset."

Nanotechnology involves manipulating atoms and molecules to create tiny devices, smaller than one-thousandth the diameter of a human hair (a nanometer is one-billionth of a meter). It is anticipated that nanomedicine, fueled by nanotechnology, will enable more personalized medical care that will be both predictive and preventive.

While considerable attention has been paid to nanomedicine, UCLA's nanopediatrics program, initially organized in May 2008, may be the first initiative to examine the promises and risks of nanodiagnostics and nanotherapeutics for children in a formal and organized manner.

Created thanks to a generous $1.8 million gift from the Mattel Children's Foundation, the program will support a nanopediatrics research core and pilot funding for projects that will potentially enable investigators to obtain grants from the National Institutes of Health.

"The Mattel Children's Foundation is excited to support this groundbreaking program in nanopediatrics, which can potentially revolutionize the research and treatment of illnesses that affect young patients," said Kevin Farr, chairman of the foundation and chief financial officer of Mattel Inc. "Our philanthropic vision is to make a meaningful difference, one child at a time, and we believe that the nanopediatrics program at Mattel Children's Hospital UCLA will bring new technologies and treatments to better the lives of children battling for their health."

Projects currently underway at UCLA include the development and application of nanodiagnostic tools such as DNA-based newborn screening tests for genetic abnormalities, the development of a new generation of nanodevices for the treatment of children with genetic diseases and cancer, and the investigation of the use of nanoparticles for diagnostic imaging both during pregnancy and after birth.

The Mattel UCLA NanoPediatrics Program will partner with the California NanoSystems Institute (CNSI) at UCLA, an integrated research center established in 2000 to encourage university collaboration with industry and enable the rapid commercialization of discoveries in nanosystems. For additional information, visit www.nanopediatrics.ucla.edu.


'/>"/>

Contact: Amy Albin
aalbin@mednet.ucla.edu
310-794-8672
University of California - Los Angeles
Source:Eurekalert

Related biology technology :

1. Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital
2. George Washington University Hospital Purchases Orthocrats TraumaCad(TM) for Orthopedic Preoperative Planning
3. Childrens Hospital of Pittsburgh of UPMC Receives Prestigious Recognition for Patient Safety Efforts in National Survey
4. Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable Genotypes
5. St. Josephs Hospital and InNexus Biotechnology Enter Collaborative Partnership
6. eGenomics Awarded First U.S. Patent Covering Rapid DNA Sequencing Technology Platform to Control Hospital-Acquired Infections
7. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
8. Truman Medical Centers Becomes One of the First Hospitals in the U.S. To Install the Worlds First Adaptive 128-slice CT Scanner
9. States First Single Incision Robotic Kidney Removal Performed at Henry Ford Hospital
10. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
11. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  MDNA Life Sciences ... development of liquid biopsy tests based on the ... an exclusive license agreement with its first international ... liquid biopsy test for prostate cancer, the Prostate ... . This is the first overseas appointment ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
(Date:2/16/2017)...  Windtree Therapeutics, Inc. (Nasdaq: WINT ... KL4 surfactant therapies for respiratory diseases, announced today ... that aerosolized KL4 surfactant reduced lung inflammation and ... model. The Company believes that these preclinical data ... supports the role of KL4 surfactant as a ...
(Date:2/15/2017)... ... ... Park Systems , a leader in Atomic Force Microscopy (AFM) since ... productivity with single click reliable nanoscale images, is now available on Park XE series ... the image once done manually by the operator producing high quality nanoscale imaging in ...
Breaking Biology Technology:
(Date:2/6/2017)... Feb. 6, 2017 According to Acuity ... driving border authorities to continue to embrace biometric ... are 2143 Automated Border Control (ABC) eGates and ... at more than 163 ports of entry across ... 2016 achieving a combined CAGR of 37%. APC ...
(Date:2/2/2017)... 2017  Central to its deep commitment to ... The Japan Prize Foundation today announced the laureates ... the envelope in their respective fields of Life ... are being recognized with the 2017 Japan Prize ... contribute to the advancement of science and technology, ...
(Date:1/26/2017)... DENVER , Jan. 26, 2017  Acuity ... Trends for Biometrics and Digital Identity".  Acuity characterizes ... digital identity when increased adoption reflects a new ... "Biometrics and digital identity are ... says Maxine Most , Principal of Acuity ...
Breaking Biology News(10 mins):